A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal

Details for Australian Patent Application No. 2004220766 (hide)

Owner Pfizer Products Inc.

Inventors Watsky, Eric Jacob; Sands, Steven Bradley; O'Neil, Brian Thomas; Harrigan, Edmund Patrick; Coe, Jotham Wadsworth

Agent Spruson & Ferguson

Pub. Number AU-A-2004220766

Parent 775095

Filing date 15 October 2004

Wipo publication date 11 November 2004

International Classifications

A61K 031/465 - Nicotine

A61K 031/44 - Non-condensed pyridines

A61P 025/34 Drugs for disorders of the nervous system

A61K 031/473 - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

A61K 031/435 - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 031/445 - Non-condensed piperidines, e.g. piperocaine

Event Publications

4 November 2004 Complete Application Filed

11 November 2004 Application Open to Public Inspection

  Published as AU-A-2004220766

18 August 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004220767-Implant with ceramic coating, and method for ceramic coating of an implant

2004220765-Method for stable estimation of anisotropic parameters for P-wave prestack imaging